Prophylactic Treatment With Oseltamivir

• Status: Completed
• Trial end date: 2020-03-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the efficacy of 5-day versus 10-day oseltamivir prophylactic treatment in patients who had been exposed to influenza.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Medical Centre Ljubljana
• Treatments: Oseltamivir

Criteria

Inclusion Criteria:

• 18 years or older

• exposure to influenza during hospitalization

• risk factors for influenza complications

• consent for participation obtained

Exclusion Criteria:

• younger than 18 years

• hematological malignancy

• hospitalized in intensive care unit

• refusal to participate